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Abstract
Placentae and mammary epithelial cells are unusual in robustly expressing
two copper “pumps”, ATP7A and B, raising the question of their individual
roles in these tissues in pregnancy and lactation. Confocal microscopic evi-
dence locates ATP7A to the fetal side of syncytiotrophoblasts, suggesting a
role in pumping Cu towards the fetus; and to the basolateral (blood) side of
lactating mammary epithelial cells, suggesting a role in recycling Cu to the
blood. We tested these concepts in wild-type C57BL6 mice and their trans-
genic counterparts that expressed hATP7A at levels 10–209 those of endoge-
nous mAtp7a. In lactation, overexpression of ATP7A reduced the Cu
concentrations of the mammary gland and milk ~50%. Rates of transfer of
tracer 64Cu to the suckling pups were similarly reduced over 30–48 h, as was
the total Cu in 10-day -old pups. During the early and middle periods of
gestation, the transgenic litters had higher Cu concentrations than the wild-
type, placental Cu showing the reverse trend; but this difference was lost by
the first postnatal day. The transgenic mice expressed ATP7A in some
hepatocytes, so we investigated the possibility that metalation of ceruloplas-
min (Cp) might be enhanced. Rates of 64Cu incorporation into Cp, oxidase
activity, and ratios of holo to apoceruloplasmin were unchanged. We con-
clude that in the lactating mammary gland, the role of ATP7A is to return
Cu to the blood, while in the placenta it mediates Cu delivery to the fetus
and is the rate-limiting step for fetal Cu nutrition during most of gestation
in mice.
Introduction
The copper “pumps”, ATP7A and ATP7B, are vital for
specific processes in mammals. Their dysfunction results
in well-known genetic diseases of copper deficiency and
overload, respectively: Menkes disease (MD) occurs when
ATP7A is mutated, and Wilson disease (WD) when
ATP7B is not functioning (La Fontaine and Mercer 2007;
Gupta and Lutsenko 2009; LaFontaine et al. 2010). Both
P-type ATPases efflux copper from cells by pumping it
from the cytosol and/or via exocytosis. They also supply
copper to cupro-enzymes in the secretory pathway. Men-
kes disease and the less deadly Occipital Horn Syndrome
(OHS) are the result of a severe copper deficiency because
of a marked decrease in the ability of copper to exit intes-
tinal enterocytes to enter the blood, after absorption from
the diet, compounded by maldistribution of copper to
internal organs. Boys with MD usually die within 3 years
of birth due to severe impairment of physiological func-
tions dependent on copper enzymes. In contrast, the pri-
mary consequence of WD is excessive accumulation of
copper in the liver and some other organs. This accumu-
lation is due to impairment of copper excretion, which
occurs primarily through the bile (Roelofsen et al. 2000;
La Fontaine and Mercer 2007; Gupta and Lutsenko 2009;
LaFontaine et al. 2010; Linder 2010). Copper accumula-
tion leads to oxidative stress and toxicosis. Untreated
humans typically die from liver failure in their teens,
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although a neurological form of WD results from accu-
mulation of copper in the brain.
In mammals, ATP7A is expressed in most cells, while
ATP7B has a much more restricted expression (La Fon-
taine and Mercer 2007; Lutsenko et al. 2007; Gupta and
Lutsenko 2009; LaFontaine et al. 2010). Both are found
in membranes of the trans-Golgi network (TGN) as well
as in vesicles cycling to and from portions of the plasma
membrane. At the TGN, both proteins supply copper to
secreted cupro-enzymes such as lysyl oxidase (ATP7A)
and ceruloplasmin (ATP7B). If copper levels rise in the
cell, both proteins move onto vesicles, which traffic to
the plasma membrane to release excess copper. This pro-
cess, termed copper-induced trafficking, is central to the
maintenance of copper homeostasis (La Fontaine and
Mercer 2007). In the intestine, copper absorbed by en-
terocytes from the diet is carried by the cytosolic copper
chaperone ATOX1 to ATP7A in the TGN, and from
there it enters endosomes destined to empty copper into
the blood via exocytosis (Lutsenko et al. 2007; Nyasae
et al. 2007; Gupta and Lutsenko 2009; LaFontaine et al.
2010; Lutsenko 2010). The form of copper released has
not been characterized, but is capable of direct binding
to the blood plasma proteins, albumin and transcuprein
that transport it (Linder 2010), suggestive of Cu(II) ions.
In hepatocytes, copper is chaperoned (also by ATOX1) to
ATP7B in the TGN and/or endosomes, from where it is
exocytosed to that portion of the plasma membrane con-
stituting the bile canaliculi (La Fontaine and Mercer
2007; Lutsenko et al. 2007; Gupta and Lutsenko 2009;
LaFontaine et al. 2010; Linder 2010). ATPB, however, is
also essential for metalation of ceruloplasmin (Cp) pro-
duced by hepatocytes and secreted into the blood plasma
(Yamada et al. 1993; Terada et al. 1998). Lysyl oxidase
produced by fibroblasts for modification of collagen and
elastin in the extracellular matrix receives copper from
ATP7A; hence patients with MD and OHS have a pro-
nounced connective tissue weakness (Kaler 2011; Kodama
et al. 2012).
While most mammalian cells express either ATP7A or
B, a few have robust expression of both. These include
the mammary epithelial cell that produces milk (Hard-
man et al. 2007) and the placental syncytiotrophoblasts
that transfer nutrients from the blood of the mother to
the fetus (Hardman et al. 2004). Prior studies from our
laboratories have shown that in the (lactating) human
breast (Ackland et al. 1999) as well as in transgenic (Tg)
mice with 10–209 more human ATP7A than murine
Atp7a (Llanos et al. 2008), ATP7A localized to the
maternal blood side of the mammary epithelium, merg-
ing with integrin in confocal microscopy. In contrast,
ATP7B was found mainly in the TGN and in endosomes
located closer to the apical side, where milk is released.
This localization suggested that during lactation, ATP7B
is mainly concerned with providing copper to milk secre-
tions. The copper released into milk would in part be
associated with Cp, which is not just in blood but is also
a major milk copper protein made by the mammary epi-
thelium (Wooten et al. 1996; Cerveza et al. 2000). As in
hepatocytes, apoceruloplasmin is likely to be metalated in
the TGN of mammary cells with copper provided by
ATP7B, followed by exocytosis, as toxic milk mice (with-
out Atp7b) have much less copper in their milk (Rauch
1983; Michalczyk et al. 2000). Other forms of copper
destined for milk might undergo a similar process,
although a direct pumping of copper ions by ATP7B
across the apical (brush border) membrane into the
developing milk cannot be excluded. (The copper-bind-
ing components of milk have not yet been adequately
defined.) Localization of ATP7A primarily on the other
side of the cell (with or without lactation) might indicate
it is effluxing copper from the mammary epithelium back
into the blood.
Our prior studies on syncytiotrophoblasts of third tri-
mester human placenta from our laboratories (Hardman
et al. 2006, 2011) indicated that ATP7A (and CTR1)
localizes to the fetal side of the human placenta (with
Na+/K+ATPase) and not to the maternal side (with trans-
ferrin receptor). In contrast, ATP7B was found by trans-
mission electron microscopy to be primarily in microvilli
of the syncytiotrophoblast, with a small proportion within
the cytoplasm adjacent to the nuclei (Hardman et al.
2011). This suggested that ATP7A might be transporting
copper from the placenta to the fetal circulation, while
ATP7B might be metalating a unique form of Cp
expressed in placenta (Yang et al. 1990) as well as its
membrane-bound homologs, hephaestin and zyklopen,
the latter also placenta-specific (Anderson et al. 2002;
Chen et al. 2004, 2010). In addition, it might play a role
in returning copper to the maternal circulation.
The study reported here was designed to test two
hypotheses about ATP7A. First that in the placenta,
ATP7A mediates the flow of copper from the mother to
the fetus by pumping or exocytosing copper in the direc-
tion of the fetal blood circulation, and that this process
could be rate-limiting for the copper nutrition of the
fetus. Second that in the mammary epithelium, ATP7A
returns copper to the blood, to mitigate against accumu-
lating copper in mammary epithelium – for example,
when lactation ceases, and prevents an excess of copper
from entering the milk. To test these hypotheses, we uti-
lized the Tg mice that produced 10–209 higher amounts
of human ATP7A than the endogenous mAtp7a (Llanos
et al. 2008) and compared the results side by side with
those for the wild type (WT). The results support our
hypotheses about the functions of ATP7A in mammary
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epithelium and placenta, and suggest that ATP7A may be
rate-limiting for copper transport to the fetus.
Methods
Animal and treatments
Experiments were performed on WT and Tg mice
expressing hATP7A produced in the C57BL/6J back-
ground strain, as previously described and characterized
(Llanos et al. 2008). In these mice, levels of hATP7A were
shown to be 10–209 higher than endogenous levels of
Atp7A by Western blotting. Pregnant, lactating, and vir-
gin female mice ranged from 2.5 to 8 months of age. All
studies were preapproved by the university IACUC. To
study copper transport, trace amounts (<1 ng) of radio-
active 64Cu(II) (20–100 lCi) were administered i.p. as
the nitrilotriacetate (NTA) complex (5–10:1 NTA:Cu
molar ratio), and mice were euthanized at various times
thereafter. In the case of lactating mice, milk was
obtained under ketamine/xylazene or pentobarbital anes-
thesia, after i.p. injection of 1U oxytocin, within the last
15 min before euthanasia by exsanguination. Plasma was
obtained from heparinized blood collected from the vena
cava. Major organs (liver, kidney, spleen, lung, brain,
skeletal muscle, mammary gland, and in some cases also
skin and skeleton) were collected for counting distribu-
tion of radioactive copper tracer. Percent dose of tracer
64Cu in a given organ or pup/fetus was calculated based
on the total radioactivity recorded in all major organs of
the dam, plus offspring. Whole pups were collected dur-
ing days 1–10 of lactation. In the case of pregnant mice,
half the uterus (with its placentae and pups) was col-
lected as a whole, making note of the number of pups;
the other half was dissected to separately collect fetuses
and placentae. Samples were stored frozen at 20oC.
Radioactivity was measured in a gamma counter (Perkin
Elmer, Model Cobra II, St. Louis, MO).
Rates of ceruloplasmin synthesis
Incorporation of 64Cu into plasma Cp was measured 2 h
after i.p. injection of isotope. The resulting Cp was
isolated from plasma after first removing endogenous
immunoglobulins with protein A beads, then treating
with anti-human Cp antibody (Sigma-Aldrich, Waltham,
MA) and precipitating with protein A beads. Washed
precipitates were counted for radioactivity. Alternatively,
equal volumes of plasma were applied to nondenaturing
tube gel electrophoresis, gels sliced, and the radioactivity
in the Cp band (Rf 0.6) was counted (Middleton and
Linder 1993). In both cases, the results were used to
calculate 64Cu incorporated into the Cp of 1 mL plasma
over 2 h. Data from combined experiments are given as
percent of the mean for WT (control) mice in a given
experiment.
Copper analysis
Concentrations of copper in samples were determined by
graphite furnace atomic absorption spectrometry, as pre-
vious described (Chu et al. 2011). Homogenates of tis-
sues and whole fetuses or pups were wet ashed with trace
element-grade nitric acid, prior to quantitation of copper
in the 1–2% nitric acid-dissolved mineral residue.
Detection of apo and holoCp
Nontraditional sodium dodecyl sulphate polyacrylamide
gel electrophoresis (SDS-PAGE, without boiling samples)
was performed to separate apo and holoCp based on pre-
vious work by our own and other laboratories (Sato and
Gitlin 1991; Middleton and Linder 1993; Hirano et al.
2005). Nontraditional and traditional SDS-PAGE (with
boiling) was carried out in 7.5% acrylamide resolving gels
and transferred to PVDF membranes, followed by immu-
noblotting with primary rabbit anti-mouse Cp antibody
(Biomatik; Wilmington, DE) and goat anti-rabbit-horse
radish peroxidase conjugate (Bio-Rad, Hercules, CA),
developing with peroxide and Luminal Enhancer solution
from Thermo Scientific (Rockford, IL). Images were
captured by Kodak Image Station 4000R (Molecular
Bioimaging, Upland, CA).
Cp enzyme activity assays
p-Phenylene-diamine (pPD) oxidase and ferroxidase
activities of whole plasma were measured as previously
described (Gray et al. 2009), the latter using an adapta-
tion of the Erel assay (Erel 1998). In the pPD assay, oxi-
dation of substrate, at pH 5.5 and 37°C, was followed at
540 nm. Ferroxidation of Fe(II) (70 lmol/L ferrous
ammonium sulfate) at pH 5.96 and 37°C was followed by
measuring the Fe(II) remaining from 1 to 5 min after the
start of substrate addition, stopping the reaction with
Ferene S, and reading absorbance of the complex at
600 nm. In some cases, Na azide (1 mmol/L) was added
to the reaction.
Statistics
Data are presented as Mean  SD for the indicated
number of determinations/samples. Statistical signifi-
cance was determined by analysis of variance (ANOVA)
and Student’s t Test, P < 0.05 being considered signifi-
cant.
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Results
Effects of excess ATP7A on copper transport
in lactation
Effects on the copper contents of mammary gland
and milk
We had postulated that ATP7A would enhance efflux of
copper back into the blood; so we expected levels of total
copper to be lower in the Tg mice, which is what we
found. Similar to our previously published report for day
7–8 of lactation (Llanos et al. 2008) (days 7–8 after
birth), overexpression of ATP7A lowered copper concen-
trations about 50% (P < 0.005), in this case in the mam-
mary gland of mice analyzed on days 2–5 of lactation
(Fig. 1A). We also expected that less copper in the mam-
mary epithelial cells would result in less transfer of copper
into milk. The results of analyzing many samples of milk
taken on days 2–5 as well as 10 days after birth are con-
sistent with what we expected and shown in Figure 1B.
Concentrations of copper in milk were 25–70% lower in
samples from mice with extra ATP7A.
Effect of excess ATP7A on transfer of tracer
copper from mother to newborn during suckling
The effects of excess ATP7A on copper transfer into milk
and to offspring was also examined using trace amounts
of radioactive copper (64Cu) injected into the dams.
Uptake of tracer by the mammary gland and liver, and its
accumulation in the suckling litters was monitored over
48 h. Figure 2A shows that in both the WT and Tg mice
(overexpressing ATP7A), the mammary gland (dark bars)
accumulated between 5% and 10% of the administered
dose of 64Cu at any of the times examined. In contrast,
accumulation of radiotracer in the suckling pups (light
bars) increased over time. The rate of increase was, how-
ever, much more rapid in the case of the WT, reaching
about 70% of the total initial dose of tracer administered,
by 48 h. This was almost twice as much as the accumula-
tion of tracer in the litters of the Tg mice. Conversely, as
seen in Figure 2B, the livers of the Tg mice (dark bars)
retained a larger proportion of the radioactive copper
than the WT at later times. It is noteworthy that the dif-
ferences in 64Cu contents in liver and pups of the WT
and Tg mice was not evident at the earlier, that is, it
developed over time. At 8 h after injection about 20% of
the total dose accounted for in the major organs of the
dam plus pups had been transferred to the litters
(Fig. 2A), and this was true for both the WT and trans-
genics. However, over the next 40 h, the total percentage
of tracer 64Cu in the WT pups increased 3.59, while that
entering the Tg litter only doubled. A summary of the
data for differences between 64Cu ending up in liver,
pups, and mammary gland after 30 and 48 h is given in
Figure 2C. For liver and pups but not mammary gland,
the differences were highly significant; and it is notewor-
thy that the drop in total transfer of radiocopper to the
pups matched the percent dose of radiocopper retained
by/returned to the maternal liver.
As in these studies the size of the litters varied from
four to seven, we carried out an additional experiment in
which transfer of 64Cu from mother to suckling pups was
measured with litters of identical size (culled to five pups
A B
Figure 1. Effects of ATP7A overexpression on copper concentrations of lactating mammary gland and milk. (A) Copper concentrations of
lactating mammary gland (2–5 days post partum) from wild-type (WT) and transgenic (Tg) mice, in lg/g. Values are Mean  SD (N = 16).
*Statistically significant decrease (P < 0.005). (B) Copper concentrations of milk (lg/mL) early (days 2–5) and later (day 10) in lactation of WT
and Tg mice. Mean  SD, for 10 WT, 9 Tg mice (Days 2–5), and 3 WT and 3 Tg mice (Day 10). *P < 0.003 for differences between WT and
Tg milk
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per dam at the time of 64Cu injection of the dam). The
same kinds of results were obtained (Fig. 2D). In this
case, we also measured the percentages of radioactive cop-
per tracer that became associated with the skeleton and
skin of the dam. We are not aware that uptake of radio-
active copper into these copper-dependent tissues has ever
been measured before, and we postulated they might rep-
resent a significant “sink” for copper. The data show that
in both the lactating WT and Tg mice, a significant but
not enormous portion (~10%) of the injected tracer 64Cu
ended up in those parts of the organism 30–48 h after
administration.
As less radioactive copper tracer was being transferred
from the dam to her litter when the mammary gland and
other organs were expressing very high levels of ATP7A,
we expected that the total copper levels in the pups would
also be less than in the WT pups. This was confirmed by
comparing the total copper contents of pups 10 days after
birth (Fig. 3). Although there was no statistically signifi-
cant difference in the weights of pups from the WT and
Tg litter (Fig. 3, right), the total copper content of the
pups was markedly and significantly less (Fig. 3, left),
though also highly variable.
Effects of excess ATP7A on copper transport
during gestation
Total copper content of litters at various stages of
gestation
In a first attempt to explore whether, as hypothesized,
ATP7A might normally be rate-limiting for transfer of
copper from mother to fetus, the copper contents of the
litters of WT and Tg mice in utero were measured at var-
C D
A B
Figure 2. Effect of ATP7A overexpression transport of copper to liver, mammary gland and pups in lactation (days 2–5), using 64Cu. (A) 64Cu
in maternal mammary gland (MG; dark bars) and suckling pups (light bars) at different times after i.p. injection of the dam. Data are percent of
64Cu dose (Means  AD or SD, for 2–4 litters per time point). (B) Copper accumulation in livers of Tg (dark bars) and WT (light bars) mice at
various times after tracer 64Cu injection (Mean  AD or SD, for 2–4 litters per time point. (C) Cumulative data for the 30 and 48 h time points
for mammary gland (MG) 910, livers and pups of Tg and WT mice. Data are percent of 64Cu dose administered (Means  SD, for 6 litters; 2
time points) *P < 0.001 for difference between WT and Tg mice. (D) Transfer of 64Cu tracer to maternal organs and pups when litters were
culled to 5 pups at time of injection, for Tg (dark bars) and WT (light bars) mice. Combined data for 30 and 48 h after injection. Percent dose
in litters. Mean  SD for four WT and seven Tg litters *Significant differences between WT and Tg: from left to right: P < 0.02, P < 0.02,
P < 0.04
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ious stages of pregnancy. As in early pregnancy it is very
difficult to separate the fetuses from the placenta and
uterus, the pups were collected in two different ways. For
a given mouse, half the uterus (with a given number of
pups) was analyzed as a whole; for the other half, fetuses,
uterus, and placentae were separated out and separately
analyzed. In Figure 4, the data obtained were plotted
(x-axis) as a function of the average weight of the fetus
plus placenta plus uterine segment involved (fetal unit).
This covered a large range of fetal weight and gestational
stage, from very early to late in pregnancy. Figure 4A and
B show that as we had predicted, copper concentrations
of the fetal units in the Tg mice were higher at least
during a major portion of the pregnancy. Moreover, the
placentae from the ATP7A transgenic animals had less
copper (Fig. 4C). These findings are consistent with the
concept that increased expression of ATP7A caused an
increase in the flow of copper to the fetuses from the pla-
centa after its uptake from the blood of the dam, and that
ATP7A is rate-limiting for copper transfer to the fetus in
pregnancy.
The concentrations of copper in the mammary gland
of the Tg mice during gestation were also examined, and
no particular trends were evident. However, overall, and
similar to what we observed in lactation, the average con-
centrations of copper of the transgenic mammary gland
during gestation was less than half that of the WT:
1.6  1.3 versus 5.8  3.0 lg/g tissue (Mean  SD,
N = 8–10; P < 0.005).
If the rate of copper transfer to the fetus in gestation
were enhanced by the excess ATP7A, we would expect
that right after birth, the pups of the Tg dams would also
have more copper. However, that did not prove to be the
case. Figure 4D shows that on the first day after birth,
the total body content of copper of the newborns was
about the same for the WT and Tg mice. As already indi-
cated, the data on fetal copper concentrations during ges-
tation were plotted not against fetal body weight on the
x-axis, but against the weight of individual fetal units (a
fetus with placenta and its portion of the uterus). If we
take into consideration the actual fetal weights at the end
of the time frame of gestation in which tissue was col-
lected, this can give us an idea of the fetal growth rate
before birth. When weights of the units were in the range
of 1.7 to 2.2 g (the last prebirth units sampled), fetal
weights averaged 1.2 g. One day after birth weights were
in the range of 1.4 g. Thus, the average pup stood to gain
about 15% of body weight from the end of gestation
through first day of life. During this period, the WT pups
seemed to make up the difference in total body copper
content (compared to the Tg pups). Overall, the results
imply that during most of gestation, ATP7A may be the
rate-limiting step in transfer of copper from mother to
fetus.
Effects of ATP7A overexpression on
metalation and activity of plasma
ceruloplasmin
In these Tg mice, some hepatocytes express ATP7A (Ke
et al. 2006), which is not normally the case. As ATP7A
like ATP7B pumps copper received from ATOX1 into the
TGN where apoceruloplasmin is thought to receive its
copper, it seemed possible that metalation of Cp might be
enhanced by the ectopic expression of ATP7A in hepato-
cytes. Alternatively, expression of ATP7A in mouse
hepatocytes might have the opposite effect, namely
enhancing efflux of copper from hepatocytes, and thus
reducing its availability to Cp. To test these possibilities,
we examined several aspects of Cp metalation and metab-
olism.
Figure 5A (right side) shows a representative immu-
noblot depicting the relative ratios of apo to holoCp in
the WT and Tg mice. Figure 5B shows the results of
densitometry. There was no obvious difference, indicat-
ing no increased metalation of the Cp present. Total
amounts of Cp protein per unit of plasma also did not
differ (Fig. 5A, left side, and 5B). The oxidase activity of
Cp, considered a good measure of the concentration of
copper-loaded Cp, was also compared (Fig. 5C, left) and
no difference was observed between plasma from the Tg
and WT mice. Rates of incorporation of tracer 64Cu into
plasma Cp were also measured by two different proce-
dures. Rates of copper incorporation into Cp for the
WT and Tg mice, determined by two different methods,
were indistinguishable (Fig. 5D). All of this indicates
Figure 3. Effect of overexpression of ATP7A also leads to less total
copper in the pups. Data for pups after 10 days of lactation. For
the Tg mice, total Cu per pup (lg) was significantly lower than that
of the WT (P < 0.025), but there was no significant difference in
body weight. Mean  SD, N = 13 and 5, for WT and Tg litters,
respectively.
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that at least at these levels of ATP7A expression in the
Tg mouse hepatocytes, there was no change in metala-
tion of Cp. Cp is also considered the major ferroxidase
in blood plasma, although knocking out its gene only
cuts total ferroxidase activity in half (Gray et al. 2009).
In the ATP7A Tg mice, total ferroxidase activity
appeared to be somewhat increased (Fig. 5C, right); but
the increased ferroxidase in the Tg mice was not inhib-
ited by azide (which inhibits Cp oxidase activity). As
there was no increase in pPD oxidase activity, the
increase in ferroxidase activity in the Tg mice is attrib-
utable to a ferroxidase that (unlike Cp) is resistant to
high concentrations of azide. This suggests that expres-
sion of excess ATP7A may have resulted in increased
copper metalation of a non-Cp ferroxidase in the blood
plasma.
The presence of excess ATP7A transgene in nonpreg-
nant and nonlactating mice did not alter the accu-
mulation of tracer 64Cu in liver, kidney, and other
organs (Fig. 6), in this case 2 h after injection. As has
been demonstrated before for rats and mice (and
humans) (Weiss and Linder 1985; Cabrera et al. 2008;
Linder 2010), almost all the tracer initially entered the
liver.
Discussion
ATP7A is more widely expressed than ATP7B in mamma-
lian cells. Earlier studies in whole animal and cultured cell
models, as well as examination of human samples, indi-
cated that the major role of ATP7A might be to transfer
copper out of cells into the blood. Thus, for example, lack
of active ATP7A, as in MD and Atp7a-mutant mice (La
Fontaine and Mercer 2007; Lutsenko et al. 2007; Kaler
2011), results in a profound decrease in transfer of dietary
copper from intestinal absorptive cells into the blood, and
a severe or fatal copper deficiency. In this condition, cells
in most organs suffer from a lack of copper due to lack
of absorption, though some accumulate copper due to
lack of efflux – such as those of the kidney proximal
tubules and blood–brain barrier.
After copper is released into the blood mediated by
ATP7A across membranes, it associates primarily with
two plasma proteins, albumin and transcuprein (Linder
et al. 1998; Liu et al. 2007; Linder 2010), which (in most
mammals) have a high affinity for copper. The other cop-
per “pump”, ATP7B, is normally expressed robustly in
only a few cell types like hepatocytes. It too is linked to
efflux of cellular copper, efflux from hepatocytes into the
A B
C
D
Figure 4. Effect of ATP7A overexpression on Cu in fetuses and placenta during gestation and at birth. (A and B) Concentrations of copper
(lg/g) in fetal units (A) and fetuses (B) from early to mid-late gestation, in WT (crosses) and Tg (squares) mice. Gestational stage was indicated
(on the x-axis) in terms of the average weight (g) of a fetus plus its placenta and its portion of the uterus (a “fetal unit”) for a given litter. (C)
Average copper concentrations of placentae for the same fetal units. (D) Total copper (lg) and body weights (g) of newborn Tg (dark bars) and
WT (light bars) pups: Mean  SD, N = 13 and 18, respectively.
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bile being a major process for regulating the overall
copper status of the body (Roelofsen et al. 2000; La Fon-
taine and Mercer 2007; Lutsenko et al. 2007; Gupta and
Lutsenko 2009; Linder 2010). ATP7B also provides copper
to Cp, the most abundant copper-containing protein in
the blood formed by hepatocytes. Lack of active ATP7B
in humans or in animal models, as well as in severe
copper deficiency, markedly reduces the secretion of cop-
per-containing Cp from liver hepatocytes into the blood.
Mammary epithelial cells express Cp (Jaeger et al. 1991;
Cerveza et al. 2000), which enters the milk (Wooten et al.
1996). Thus, knocking out Cp results in a marked drop
in milk copper concentrations (Chu et al. 2011), again
suggesting that ATP7B is responsible for metalation of a
secreted copper protein. Apart from copper in Cp, it is
not known in what form copper is secreted into milk or
excreted into bile, including whether it is only bound to
proteins (Linder 2010). The same is the case for copper
released from cells via ATP7A.
In the studies reported here, we tested the hypothesis
that ATP7A is a copper efflux protein that even in the
lactating mammary epithelium (during overall transfer of
copper to the milk) pumps copper back into the blood.
We also tested the hypothesis that ATP7A might be rate-
limiting for transfer of copper from placental cells to the
fetus (across the basolateral membrane into the fetal
circulation) during gestation, when substantial quantities
A B
C D
Figure 5. Expression, activity, Cu-saturation of, and rate of Cu incorporation into ceruloplasmin (Cp), in Tg and WT mice. (A) Levels and
copper saturation of Cp determined by Western blotting for Cp following SDS-PAGE of equal volumes of denatured (left) or undenatured (not
boiled; right) samples of plasma from WT and Tg mice (representative blots). Total levels of plasma Cp protein (132 kDa; left) and relative
proportions of apo and holoCp in WT and Tg plasma are indicated. (B) Ratios of holo to apoCp calculated from densitometry of Western blots
like those in (A). Mean  SD (N = 4). C. Plasma p-phenylene diamine (pPD) oxidase activity (pmol/min/mL) and ferroxidase activity (nmol/min/
mL). Values are Mean  SD, for N = 7–11, and N = 7–9, respectively. Ferroxidase activity was also measured in the presence of azide (N = 3
and 4 for WT and Tg mice, respectively). Azide significantly inhibited activity for plasma of both WT and Tg mice (P < 0.03). D. Rate of
incorporation of 64Cu into plasma Cp over 2 h in Tg and WT mice, as determined by immunoprecipitation (left) or extraction of purified Cp
from gels after native PAGE. Values are Mean  SD (N = 5) as percent of the WT controls in a given experiment (P > 0.05).
Figure 6. Excess ATP7A does not cause differences in rates of
64Cu tracer accumulation in body organs over 2 h. Radioactive
copper in the major organs of WT (dark bars) and Tg (light bars)
mice 2 h after 64Cu tracer injection (as percent of dose in the
indicated organs and blood). Mean  SD (N = 13 and 14). There
were no statistically significant differences.
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of this trace element are needed in support of fetal
growth and prenatal storage in liver (Linder 2010). The
results of our studies on lactation provide strong support
for our hypothesis that ATP7A effluxes copper from
mammary epithelial cells back into the blood. When the
hATP7A transgene was expressed in mice, copper concen-
trations of mammary gland and milk were reduced by
about half; rates of transfer of tracer copper from dam to
pups were also markedly reduced; and suckling pups from
the Tg mothers accumulated much less copper than those
of the WT during the first 10 days of lactation (although
there was no differences in growth rate, as evident from
body weight). Interestingly, when monitoring the rate of
accumulation of radioactive copper tracer in the suckling
pups, differences between the results for the WT and Tg
litters only became significant at later times. Eight hours
after injection, the same percentage of tracer was recov-
ered in the pups of the WT and Tg litters, whereas in the
next 22–40 h, the percentage increased about 3.59 in the
WT, but only 1.5–29 in the litters of the Tg dams. This
suggests that two different pools of 64Cu in the mammary
epithelial cells may be entering milk at different rates, an
initial (faster) one not affected by ATP7A, and a second
one depleted by excess ATP7A pumping copper back into
the blood. It is possible that the copper is entering these
pools from two different blood plasma sources. The first
would be contributed by albumin and transcuprein,
which are immediately labeled with the radioactive tracer
and rapidly deliver it to cells of the liver and mammary
gland in lactation (Weiss and Linder 1985; Donley et al.
2002); the second would be from radiotracer in plasma
Cp, which is incorporated within hepatocytes and appears
in the blood later on, after tracer has virtually disappeared
from the other two plasma proteins. (Recent evidence
from cell culture studies confirms earlier observations
from our laboratory; Campbell et al. 1981; Orena et al.
1986; Lee et al. 1993; Linder 2010; that Cp transfers cop-
per directly to cells; Danny Ramos, David Mar, Michael
Ishida, Maria Linder, unpubl. data.) In the current stud-
ies, we found that it took at least 2 h after radioactive
copper injection for substantive amounts of labeled Cp to
emerge in the blood.
While the mammary gland of the mice expressing the
ATP7A construct retained less copper, both in terms of
radioactive tracer and in terms of actual copper measured
by atomic absorption, the livers of these mice had more
tracer than in the WT. This is consistent with radiotracer
effluxing back into the blood through ATP7A, emerging
as ionic copper, and returning to the liver bound to albu-
min and transcuprein, the main organ taking up copper
from these proteins (Fig. 6) (Lee et al. 1993; Linder
2010). The results of these studies clearly demonstrate for
the first time the role of ATP7A of returning copper to
the blood from a second cell type (the first being intesti-
nal enterocytes), namely that of the mammary epithelium,
and one where both copper “pumps” play important but
probably very different specific roles.
Although initial analysis of the Tg hATP7A mice indi-
cated expression of the latter in some hepatocytes (Ke
et al. 2006), the current data indicate that this ectopic
expression of ATP7A in hepatocytes did not significantly
enhance rates of copper incorporation into Cp that
entered the blood, nor did it increase metalation of this
protein – as measured by ratios of holo to apoCp in the
plasma, and by assays of Cp oxidase activity. Possibly, the
fraction of hepatocytes-expressing ATP7A in these mice
was too low to cause any detectable alterations in Cp
metalation coupled with the fact that the ATP7A may be
primarily located on the plasma membrane (Ke et al.
2006) rather than the TGN where the metalation of Cp
occurs.
Turning to our findings on the role of ATP7A in gesta-
tion, these showed that overexpression of ATP7A did
increase the rate of copper transport to the fetus, suggest-
ing that during much of gestation ATP7A is rate-limiting
for copper transport. The confounding result, however,
was that when pups were sampled on day 1 after birth,
the difference between the Tg and WT had disappeared.
The total copper data for fetuses scattered from early
through middle and even later levels of gestation strongly
suggest that those with extra ATP7A initially have some
advantage in gaining copper from their dams. Even if one
pools the data from throughout pregnancy in Figure 4B,
which show two parallel lines of increasing concentrations
progressing with pregnancy stage, mean copper concen-
trations were slightly higher in the case of the Tg mice than
in the WT. Moreover, concentrations in the placentae dem-
onstrated the reverse phenomenon, consistent with excess
ATP7A pumping more copper into the fetal circulation.
This is good evidence that ATP7A-mediated copper
transport is the rate-limiting step in the transfer of copper
from mother to fetus during most of pregnancy.
However. by day 1 of lactation, after birth, the Tg pups
no longer had more copper than the WT. One possible
explanation is that at the time of sampling they had
already used up the extra copper acquired during gesta-
tion for their growth and obtained less copper from the
milk produced by the Tg dam, resulting in the change
observed. Another possibility is that in the very last part
of gestation, there was increased expression of placental
mAtp7A in the WT, which allowed them to “catch up”
with their transgenic counterparts. As calculated earlier,
the oldest fetuses analyzed for total copper were about
85% of their birth weight, indicating they still had a few
days in which to gain additional copper. Mammalian
fetuses accumulate stores of iron, copper. and zinc in
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2014 | Vol. 2 | Iss. 1 | e00195
Page 9
J. Wadwa et al. Functions of ATP7A in Lactation and Gestation
their livers before birth, which are used up during lacta-
tion (Linder 1991, 2010). Based on human studies, almost
half of the excess iron stored in liver accumulates in the
last 2 months of gestation. The same may be true for
liver copper stores. As ATP7A is not associated with cop-
per uptake by placental (or other) cells, but is expressed
on the fetal side, this suggests that copper uptake is
enhanced in the last part of gestation. Based on what is
currently known, this would involve delivery of copper
on plasma proteins to copper transporter 1 (CTR1) (Lee
et al. 2002a; Lutsenko et al. 2007; Gupta and Lutsenko
2009; Wang et al. 2011) and/or to other copper trans-
porters yet to be identified (Lee et al. 2002b; Kidane et al.
2012). In addition to albumin and transcuprein, Cp may
be a donor, as we had previously demonstrated with i.v.
injections of 67Cu-labeled Cp into rats that showed a
placental preference for copper from this protein (Lee
et al. 1993). Moreover, Cp levels are increased in preg-
nancy (especially in the last third), making this copper
more available. Our findings provide new insight into the
mechanisms by which ATP7A participates in (and sup-
ports) the copper nutrition of the fetus, and how it may
mitigate against the transfer of too much copper to the
newborn after birth.
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